Edward J. Benz JR

Insider Reports History

Location
Waltham, MA
Signature
/s/ Charles Schoch, as Attorney-In-Fact for Edward J. Benz Jr.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Edward J. Benz JR:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Deciphera Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 0 $0 $10.58 11 Jun 2024 Direct
Candel Therapeutics, Inc. Director Stock Option (Right to Buy) 14.2K 17 Jun 2025 Direct
Renovacor, Inc. Director Common Stock 0 $8.00 01 Dec 2022 Direct
Renovacor, Inc. Director Stock Option 0 01 Dec 2022 Direct

Insider Reports Filed by Edward J. Benz JR

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CADL Candel Therapeutics, Inc. 17 Jun 2025 1 $0 4 Director 18 Jun 2025, 08:38
CADL Candel Therapeutics, Inc. 26 Jun 2024 1 $0 4 Director 27 Jun 2024, 08:34
NA Deciphera Pharmaceuticals, Inc. 11 Jun 2024 5 $0 4 Director 11 Jun 2024, 20:30
CADL Candel Therapeutics, Inc. 28 Jun 2023 1 $0 4 Director 29 Jun 2023, 09:00
DCPH Deciphera Pharmaceuticals, Inc. 21 Jun 2023 1 $0 4 Director 23 Jun 2023, 16:05
RCOR Renovacor, Inc. 01 Dec 2022 5 $0 4 Director 05 Dec 2022, 20:22
CADL Candel Therapeutics, Inc. 13 Oct 2022 1 $0 4 Director 17 Oct 2022, 16:36
DCPH Deciphera Pharmaceuticals, Inc. 23 Jun 2022 1 $0 4 Director 24 Jun 2022, 16:05
RCOR Renovacor, Inc. 25 May 2022 1 $0 4 Director 27 May 2022, 16:04
RCOR Renovacor, Inc. 03 Sep 2021 1 $0 4 Director 08 Sep 2021, 19:02
RCOR Renovacor, Inc. 02 Sep 2021 0 $0 3 Director 08 Sep 2021, 09:23
CADL Candel Therapeutics, Inc. 26 Jul 2021 0 $0 3 Director 26 Jul 2021, 21:24
DCPH Deciphera Pharmaceuticals, Inc. 23 Jun 2021 1 $0 4 Director 25 Jun 2021, 16:00